Pembrolizumab Supplier-Buyer Network — Trade Flow Analysis

Name: Pembrolizumab Supplier-Buyer Trade Network Dataset — 34+ Indian Exporters, 15+ Importers, 21+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Pembrolizumab supplier network, Pembrolizumab buyers, pharmaceutical export India, Pembrolizumab trade data

TransData Nexus

Pembrolizumab

India Pharmaceutical Trade Intelligence

$1.9M34 Suppliers21 CountriesHS 30021500

ExportsIndia → BRAZIL44.6%India → ZIMBABWE8.5%

ImportsIRELAND → India$2.3B SINGAPORE → India$85.8M

#1 Supplier: GNH INDIA #1 Buyer: INDIRA GANDHI

Who Supplies Pembrolizumab? Top Manufacturers & Buyers 2026 — GNH INDIA PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1GNH INDIA PHARMACEUTICALS LIMITED

GNH INDIA PHARMACEUTICALS LIMITED is the first-largest Pembrolizumab exporter from India, with a market share of 10.6% and a total export value of $204.6K across 6 shipments. Their average shipment value of $34.1K is above the market average of $9.0K, suggesting premium or bulk contract pricing.

GNH INDIA PHARMACEUTICALS LIMITED serves 2 named buyers in our database. TO THE ORDER is the dominant customer, accounting for 61.0% of this supplier's tracked business. Top customers include:

• TO THE ORDER — $124.8K across 4 shipments (61.0% of this supplier's total exports)

• TO THE ORDER — $79.8K across 2 shipments (39.0% of this supplier's total exports)

Key Insight: GNH INDIA PHARMACEUTICALS LIMITED's per-shipment value of $34.1K is 280% above the market average of $9.0K, consistent with large-order contracts or value-added formulations.

2VAMA LIFECARE PRIVATE LIMITED

VAMA LIFECARE PRIVATE LIMITED is the second-largest Pembrolizumab exporter from India, with a market share of 9.4% and a total export value of $181.3K across 19 shipments. Their average shipment value of $9.5K is above the market average of $9.0K, suggesting premium or bulk contract pricing.

VAMA LIFECARE PRIVATE LIMITED serves 4 named buyers in our database. AS PER INVOICE is the dominant customer, accounting for 58.3% of this supplier's tracked business. Top customers include:

• AS PER INVOICE — $105.6K across 11 shipments (58.3% of this supplier's total exports)

• EXP CODE — $29.5K across 3 shipments (16.3% of this supplier's total exports)

• EXP CODEE00260 ANANIAS GUILHERME — $27.5K across 3 shipments (15.2% of this supplier's total exports)

• AS PER INVOICE AS — $18.7K across 2 shipments (10.3% of this supplier's total exports)

Key Insight: VAMA LIFECARE PRIVATE LIMITED's per-shipment value of $9.5K is 6% above the market average of $9.0K, consistent with large-order contracts or value-added formulations.

3GEMINI HEALTHWORLD LLP

GEMINI HEALTHWORLD LLP is the third-largest Pembrolizumab exporter from India, with a market share of 8.8% and a total export value of $169.7K across 26 shipments. Their average shipment value of $6.5K is below the market average of $9.0K, reflecting a high-volume, competitive pricing strategy.

GEMINI HEALTHWORLD LLP serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• RICARDO LUIZ BARBOZA — $47.4K across 7 shipments (28.0% of this supplier's total exports)

• ERINEA FERRAZ DOS — $47.2K across 7 shipments (27.8% of this supplier's total exports)

• ERIKA CARDOSO DA SILVA — $28.2K across 4 shipments (16.6% of this supplier's total exports)

• IGOR ARGEL STECKERT — $28.1K across 4 shipments (16.6% of this supplier's total exports)

• MARIA DAS GRACAS BER — $18.8K across 3 shipments (11.1% of this supplier's total exports)

Key Insight: GEMINI HEALTHWORLD LLP operates with high shipment frequency (26 shipments) at a per-shipment value of $6.5K, indicating a broad distribution network with many smaller, regular orders.

4SHREE KRISHNA LIFECARE

SHREE KRISHNA LIFECARE is the fourth-largest Pembrolizumab exporter from India, with a market share of 8.6% and a total export value of $165.0K across 10 shipments. Their average shipment value of $16.5K is above the market average of $9.0K, suggesting premium or bulk contract pricing.

SHREE KRISHNA LIFECARE serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• KARLENE SMALL — $53.3K across 3 shipments (32.3% of this supplier's total exports)

• KEISHA YOUNG-HENRY — $47.8K across 3 shipments (29.0% of this supplier's total exports)

• TERRENCE FORRESTER — $25.9K across 2 shipments (15.7% of this supplier's total exports)

• KEISHA YOUNG-HENRY — $20.5K across 1 shipments (12.4% of this supplier's total exports)

• PROCUREMENT OFFICER — $17.5K across 1 shipments (10.6% of this supplier's total exports)

Key Insight: SHREE KRISHNA LIFECARE's per-shipment value of $16.5K is 84% above the market average of $9.0K, consistent with large-order contracts or value-added formulations.

5SPECIALITY MEDICINES PRIVATE LIMITED

SPECIALITY MEDICINES PRIVATE LIMITED is the fifth-largest Pembrolizumab exporter from India, with a market share of 7.8% and a total export value of $150.2K across 19 shipments. Their average shipment value of $7.9K is below the market average of $9.0K, reflecting a high-volume, competitive pricing strategy.

SPECIALITY MEDICINES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER — $62.9K across 8 shipments (41.9% of this supplier's total exports)

• TO THE ORDER OF — $55.4K across 7 shipments (36.9% of this supplier's total exports)

• TO THE ORDER OF — $12.9K across 2 shipments (8.6% of this supplier's total exports)

• BETANIA DALBEM DIAS — $9.5K across 1 shipments (6.4% of this supplier's total exports)

• PATIENT BETANIA DALB — $9.5K across 1 shipments (6.4% of this supplier's total exports)

Key Insight: SPECIALITY MEDICINES PRIVATE LIMITED operates with high shipment frequency (19 shipments) at a per-shipment value of $7.9K, indicating a broad distribution network with many smaller, regular orders.

63S PHARMACEUTICALS INDIA PRIVATE LIMITED

3S PHARMACEUTICALS INDIA PRIVATE LIMITED is the fifth-largest Pembrolizumab exporter from India, with a market share of 6.9% and a total export value of $132.5K across 12 shipments. Their average shipment value of $11.0K is above the market average of $9.0K, suggesting premium or bulk contract pricing.

3S PHARMACEUTICALS INDIA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• FOR THE ORDER OF — $38.5K across 3 shipments (29.0% of this supplier's total exports)

• FOR THE ORDER OF PEY — $37.3K across 3 shipments (28.2% of this supplier's total exports)

• FOR THE ORDER OF MAR — $19.1K across 2 shipments (14.4% of this supplier's total exports)

• FOR THE ORDER OF FRA — $19.1K across 2 shipments (14.4% of this supplier's total exports)

• FOR THE ORDER OF PEY — $18.5K across 2 shipments (13.9% of this supplier's total exports)

Key Insight: 3S PHARMACEUTICALS INDIA PRIVATE LIMITED's per-shipment value of $11.0K is 23% above the market average of $9.0K, consistent with large-order contracts or value-added formulations.

1Brazil

Brazil ranks as the first-largest destination for Pembrolizumab imports from India, with a total trade value of $860.1K across 41 shipments — representing a 44.6% share of all Pembrolizumab exports. The average shipment value of $21.0K is above the global average of $9.0K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Pembrolizumab importers in Brazil: AS PER INVOICE is the largest buyer, accounting for 12.3% ($105.6K) of this market's total imports.

• AS PER INVOICE — $105.6K (12.3% of Brazil's total)

• F AGAINST PROFORMA INVOICE — $48.9K (5.7% of Brazil's total)

• RICARDO LUIZ BARBOZA — $47.4K (5.5% of Brazil's total)

Key Insight: Brazil's per-shipment average of $21.0K (134% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Pembrolizumab imports from India.

Primary Market

Secondary Market

2Zimbabwe

Zimbabwe ranks as the second-largest destination for Pembrolizumab imports from India, with a total trade value of $163.5K across 0 shipments — representing a 8.5% share of all Pembrolizumab exports. The average shipment value of $163.5K is above the global average of $9.0K, indicating high-value procurement contracts or branded formulations.

Key Insight: Zimbabwe's per-shipment average of $163.5K (1721% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Zimbabwe is a key market for Pembrolizumab imports from India.

Primary Market

Secondary Market

3Maldives

Maldives ranks as the third-largest destination for Pembrolizumab imports from India, with a total trade value of $161.9K across 30 shipments — representing a 8.4% share of all Pembrolizumab exports. The average shipment value of $5.4K is below the global average of $9.0K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.

Named Pembrolizumab importers in Maldives: INDIRA GANDHI MEMORIAL HOSPITAL is the largest buyer, accounting for 80.4% ($130.1K) of this market's total imports.

• INDIRA GANDHI MEMORIAL HOSPITAL — $130.1K (80.4% of Maldives's total)

Key Insight: Maldives receives frequent, smaller shipments of Pembrolizumab — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Maldives is a key market for Pembrolizumab imports from India.

Primary Market

Secondary Market

4Jamaica

Jamaica ranks as the fourth-largest destination for Pembrolizumab imports from India, with a total trade value of $161.5K across 4 shipments — representing a 8.4% share of all Pembrolizumab exports. The average shipment value of $40.4K is above the global average of $9.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Pembrolizumab importers in Jamaica: KARLENE SMALL is the largest buyer, accounting for 33.0% ($53.3K) of this market's total imports.

• KARLENE SMALL — $53.3K (33.0% of Jamaica's total)

• KEISHA YOUNG-HENRY — $47.8K (29.6% of Jamaica's total)

Key Insight: Jamaica's per-shipment average of $40.4K (350% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Jamaica is a key market for Pembrolizumab imports from India.

Primary Market

Secondary Market

5Georgia

Georgia ranks as the fifth-largest destination for Pembrolizumab imports from India, with a total trade value of $150.4K across 6 shipments — representing a 7.8% share of all Pembrolizumab exports. The average shipment value of $25.1K is above the global average of $9.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Pembrolizumab importers in Georgia: MERMISI LLC is the largest buyer, accounting for 39.8% ($59.9K) of this market's total imports.

• MERMISI LLC — $59.9K (39.8% of Georgia's total)

Key Insight: Georgia's per-shipment average of $25.1K (179% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Georgia is a key market for Pembrolizumab imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Pembrolizumab.
2.Flow Mapping: 34 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 215 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 21 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

215 Verified Shipments

34 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Pembrolizumab

Pembrolizumab

Who Supplies Pembrolizumab? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Pembrolizumab? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Pembrolizumab Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1GNH INDIA PHARMACEUTICALS LIMITED

2VAMA LIFECARE PRIVATE LIMITED

3GEMINI HEALTHWORLD LLP

4SHREE KRISHNA LIFECARE

5SPECIALITY MEDICINES PRIVATE LIMITED

63S PHARMACEUTICALS INDIA PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Pembrolizumab Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Pembrolizumab Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Brazil

2Zimbabwe

3Maldives

4Jamaica

5Georgia

People Also Ask — Pembrolizumab Supplier & Trade Network

Pembrolizumab Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology